Melanotan II is commonly investigated for melanocortin receptor activity and pigmentation-related signaling, while UV-exposure models are researched for melanogenesis and pigmentation-adaptation pathways
GLP-1 and Blood Pressure: What the Evidence Shows GLP-1 receptor agonists, primarily licensed for type 2 diabetes and obesity management, have demonstrated modest blood pressure-lowering effects in clinical trials
For someone with obesity, the cardiovascular risk reduction from losing 25% of their body weight almost certainly exceeds the risk from a 5 to 10 beat per minute resting heart rate increase
2025 Jan 23:S0190-9622(25)00126-4
Curti D, Dagani F, Galmozzi MR, Marzatico F
Reduced Inflammation: Minimizes swelling and discomfort for faster recovery